LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to measure the depigmenting effect of a serum product
called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper
Pigmentation)